Not Applicable
Not Applicable
The methods and systems herein relate to orthopedic surgical techniques and in particular to the field of tissue microfracture.
Microfracture techniques are used to induce tissue repair or fibrocartilage repair of cartilage defects in articular surfaces. A surgeon may practice microfracture techniques with a sharp tipped tissue pick tool used to impact a tissue or bone. To repair bone, surgeons generally pass the sharp tipped tissue pick tool through a surgical portal made in soft tissue to reach a bone. The sharp tipped tissue pick tool can badly damage articular surfaces during this process. Also, when a sharp tipped tissue pick is presented to the bone at an angle and then struck with a mallet it can slide on the bone creating undesirable groves in the bone surface rather than producing surgically advantageous micro fractures.
U.S. Patent Publication No. 2006/0235419 A1 to Steinwachs et. al., filed Mar. 3, 2006 entitled “Medical Instrument for Performing Microfracturing in a Bone”, which is herein incorporated by reference in its entirety, discloses an instrument to perform bone microfracture in a bone.
In an aspect of the invention, methods and systems include a tissue microfracture apparatus that includes a housing having proximal and distal ends, the distal end including an aperture; an elongated member having proximal and distal ends with at least one tissue microfracture spike protruding from the distal end, the member operating cooperatively with the housing to expose a portion of the at least one spike through the aperture; and a disposing facility between the elongated member and the housing to dispose the at least one spike in a home position within the housing. In the aspect, the disposing facility is positioned at the proximal end of the housing. The disposing facility is positioned at the distal end of the housing. The disposing facility can comprise a resilient element such as a spring. The aspect further includes a force-receiving surface coupled to the proximal end of the elongated member for receiving a force that facilitates exposing the portion of the at least one spike. The apparatus further includes an exposure limiting facility to limit the exposed portion of the at least one spike.
In another aspect of the invention, methods and systems include a tissue microfracture apparatus that includes a housing having proximal and distal ends, the distal end including an aperture; an elongated member having proximal and distal ends with at least one tissue microfracture spike protruding from the distal end, the member operating cooperatively with the housing to expose a portion of the at least one spike through the aperture; and an exposure limiting facility to limit the exposed portion of the at least one spike. In the aspect, the exposure limiting facility can be positioned at the proximal end of the housing or at the distal end of the housing. The exposure limiting facility may comprise a resilient element such as a spring. In the aspect, the apparatus further includes a force-receiving element coupled to the proximal end of the elongated member for receiving a force that facilitates exposing the portion of the at least one spike. In the aspect, the apparatus further comprises a disposing facility between the elongated member and the housing to dispose the at least one spike in a home position within the housing.
In yet another aspect of the invention, methods and systems include a method of tissue microfracture that includes receiving a force on a force-receiving surface of a tissue microfracture apparatus thereby causing a portion of a spike to protrude through an aperture in an operative end of the apparatus and retracting the spike through the aperture. In the aspect, receiving a force on the head portion of the tissue microfracture apparatus further includes increasing a retraction force from an initial value, and retracting the spike through the aperture comprises reducing the retraction force to the initial value. The portion of the spike to protrude through the aperture can be limited independent of the retraction force. The retraction force can be provided by a disposing facility that is positioned at a proximal end of the apparatus or at a distal end of the apparatus. In the aspect, the portion of the spike to protrude through the aperture is limited by an exposure limiting feature of the apparatus other than an exterior surface of the operative end. The exposure limiting feature can be positioned at an end of the apparatus opposite the operative end or at the operative end of the apparatus.
These and other systems, methods, objects, features, and advantages of the present invention will be apparent to those skilled in the art from the following detailed description of the preferred embodiment and the drawings. All documents mentioned herein are hereby incorporated in their entirety by reference.
A tissue microfracture apparatus may be configured with features that significantly improve the safety and accuracy of such microfracture procedures while improving the quality, repeatability, and overall results. Features such as spike retractability, recessed surgical spike(s), penetration limiting, impact absorption, position stabilizers, and the like make delicate surgical procedures, such as tissue and bone microfracture, easier and therefore may improve the outcome of the procedure and recovery of the patient.
One embodiment of a tissue microfracture apparatus comprises a housing having a proximal end and a distal end that includes an aperture. The apparatus also includes an elongated member having proximal and distal ends with at least one tissue microfracture spike protruding from the distal end. The member operates cooperatively with the housing to expose a portion of the spike through the aperture. Some embodiments of the apparatus also include a disposing facility that engages the elongated member and the housing to dispose the spike in a home position within the housing. The elongated member may include a force-receiving element on the proximal end for receiving a force that facilitates exposing the portion of the spike. Some embodiments of the apparatus may also include an exposure limiting facility that limits the exposed portion of the spike.
As shown in
The microfracture apparatus disclosed can be of any shape appropriate for use with both bone and tissue microfracture. For illustration only, for the embodiment shown in
The elongated member 108 performs the function of a force rod by transmitting a portion of a force applied to the cap 132 (if present) or elongated member proximal end 134 to the spike 110. In this way, the elongated member may connect the spike 110 to the force-receiving surface.
The spike 110 may include a sharp edge or point suitable for forcibly penetrating a surface, such as bone, soft tissue or the like. It is contemplated that embodiments of the microfracture apparatus may include replaceable spikes 110 that can be exchanged for other spikes 110. Various spike shapes, sizes, materials, finishes, and the like are contemplated and included herein. Preferably, the spike material is a hardened metal or similarly rigid surgical material.
In the embodiment of
Although many of the embodiments discussed herein illustrate a disposing facility that is compressed when a force is applied and the facility returns the spike to a home position by counteracting that compressive force, it is contemplated that embodiments of the assembly can function properly when the disposing facility is any other resilient material that can similarly react to the force such as a spring, rubber, air bubbles or elastic in tension.
With this embodiment of
Referring to
In an embodiment that comprises an elongated member 108 and a housing 102 each with at least two opposing flat side walls (e.g a rectangle, an octagon, and the like), the lower guides 122 and 118 may comprise a protrusion from the at least two opposing sidewalls. Other embodiments of the exposure limiting facility may comprise buttons, nubs, or other movement restricting elements positioned to interfere when the elongated member 108 moves relative to the housing 102.
Although any length of exposure of the spikes is suitable as long as they reach the proper tissue surface, such as “bleeding bone”, preferable exposure lengths for microfracture use are in the range of about 1 to 4 mm or more preferably 2 mm.
The exposure limiting facility of the apparatus can also ensure that the elongated member distal end 138 does not contact the surface of the item (e.g. tissue) that receives the at least one spike 110. In this way the portion of the surface surrounding the penetration point(s) of the at least one spike 110 is not directly impacted by the force applied to the force receiving surface 132 that causes the at least one spike 110 to penetrate the surface. This provides the benefit of virtually eliminating undesirable damage to the surface surrounding the at least one spike 110. In the embodiment of
The operative end 120 exterior surface may further include a shock absorbing material 140 that may mitigate the force applied to the surface of the bone that is contacted by the operative end 120. The shock absorbing material 140 may absorb a portion of the force transmitted from the elongated member 108 to the housing 102 as a result of the exposure limiting facility.
The housing distal end 120 or the elongated member distal end 138 may also be curved to more accurately reflect the surface shape of the tissue to be microfractured. This surface shape may be convex or concave or a complex curved surface. Alternatively, the distal end of the housing may include a conforming element that automatically adjusts to the tissue surface. In an example and without limitation, the confirming element may be a flexible material such as rubber.
Limiting the exposure of the at least one spike 110 can be accomplished by the exposure limiting facilities as shown in the embodiments of
In an alternate to the embodiments of
The disposing facility 404 may be a resilient compressible material which responds to a compression force by first compressing and then expanding to a pre-compression size. As discussed herein, the disposing facility may also be a resilient material that provides the same force features in tension. The disposing facility 404 may be a fabricated portion of the housing 402 or a separately fabricated facility that is attached between a main portion of the housing 408 and a lower portion of the housing 410 that may include the operative end 420.
The elongated member 108 may perform the function of a force rod by transmitting a portion of a force applied to the cap 132 or elongated member proximal end 134 to the spike 110. In this way, the elongated member may connect the spike 110 to a force-receiving surface (e.g. the cap 132).
In the embodiment of
Referring to
The exposure limiting facility of the apparatus may include adjustable features that allow a surgeon to determine the depth of penetration of the spike into a bone or other tissue. The exposure limiting facility may be adjustable through a feature that allows the housing upper or lower guide elements to be repositioned along the length of the housing. In particular, embodiments can include adjustable/threaded elements that facilitate positioning the exposure limiting facility elements and may include visible marks on the apparatus to indicate exposure. The amount of exposure may also be adjusted by placing various thickness spacers between the elongated member guide elements and the housing guide elements. The amount of exposure may also be adjusted by adjusting an amount of the spike that protrudes from the distal end of the elongated member. Other methods and techniques for adjusting a spike exposure limit are contemplated and included herein.
An exposure limiting dial 702 may be threaded on the elongated member threaded end 712 so that it is disposed between the force-receiving surface 704 and the open housing end 728. The exposure limiting dial 702 may be mated with the threaded end 712 so that when the dial 702 is rotated, it moves toward or away from the force-receiving surface 704. As an example, rotating dial 702 clockwise will move dial 702 away from the force-receiving surface 704 and toward the housing open end 728.
Referring to
Referring again to
Although the above embodiment describes an adjustable exposure limiting facility comprising the interaction of threaded dials on a threaded end of the elongated member, any method of adjusting the movement of the spikes or elongated member in relation to the housing distal end is contemplated. Examples of other embodiments include but are not limited to having an adjustable protrusion of the spikes from the elongated member distal end, an adjustable cap on the distal end of the housing, having an adjustable housing guide element interact with a stationary elongated member guide element or any other means to adjustably limit the movement or exposure of the spikes relative to housing elements and the housing aperture. Other embodiments of providing marks or other calibration means reflecting the exposure of the spikes are also contemplated.
Referring to
Considering the embodiments of retractable safety bone microfracture apparatus described above, at a limit of exposure provided by an exposure limiting facility, the disposing element may be resisting the force applied to the force-receiving surface. However, the disposing element may not have reached a maximum resistance when the exposure limit is achieved. By the exposure limiting facility preventing the disposing element from reaching a maximum resistance, the portion of the at least one spike being exposed through the aperture may not be limited by the disposing element. In this way, a surgeon can ensure that applying a force that is sufficient to overcome the disposing element resistance will expose the at least one spike to a length provided by the exposure limiting facility rather than to a shorter length determined by the maximum resistance of the disposing element.
It is also contemplated that the exposure limitation of the spike may be performed by limiting the amount of force applied to the force-receiving surface. If the amount of force applied to the force-receiving surface is less than the resistance force provided by the disposing facility, this point of disposing facility compression may function as the exposure limiting facility. Embodiments of this type are contemplated where the force applied to the force-receiving surface can be varied in a predictable manner. This situation may be possible if the force is applied by a trigger mechanism driven by a calibrated spring, a calibrated pneumatic driver, calibrated electric driver or similar methods of applying a variable force.
Generally, embodiments of methods to use the apparatus comprises receiving a force on the force-receiving surface of the elongated member which causes a portion of a spike to be exposed through an aperture in the distal end of the apparatus and the disposing facility retracts the spike into a home position within the apparatus. For illustration purposes, and not for limitation, the operational use of one embodiment of the tissue microfracture apparatus is described below as used with an arthroscopic bone microfracture procedure. It is understood that other embodiments of the apparatus, as well as other embodiment of the methods are contemplated such as, but not limited to open bone microfracture procedures as well as microfracture procedures for soft tissues.
The use of embodiments of the present invention can also accompany other microfracture procedures and techniques such as but not limited to diagnostic evaluation of the patient and the tissue as well as tissue preparation and clot formation. An example of some of these procedures are described in U.S. Pat. No. 6,960,214 to Burkinshaw, filed Jan. 21, 2003 entitled “Method for Performing Automated Microfracture” which is herein incorporated by reference in its entirety.
In one example of operation of a retractable safety bone microfracture apparatus during arthroscopic surgery, a tissue microfracture apparatus such as shown in
At this point of the present methods, the bone under the defect has been debrided of cartilage tags by means selected by the surgeon. The tissue microfracture apparatus is inserted through a patient portal that provides access to a bone. Because the spike is disposed within the housing, the apparatus can be inserted without having the spike engage the soft tissue. Once the apparatus is inserted, the distal end of the housing is positioned against a surface to be microfractured. The rough surface of the operative end of the microfracture apparatus facilitates holding the apparatus in position on the exposed bone. The proximal end of the apparatus is outside of the portal and may be held in the surgeon's hand. The force-receiving surface or cap of the apparatus is also exposed to the surgeon.
To this point in the procedure, the disposing facility of the apparatus has disposed the spikes completely within the housing in a home position so that the spikes have not been exposed to the tissue of the patient.
With this assembly held in place by the surgeon, a mallet or other striking tool is then used to impact the force-receiving surface of the apparatus. The elongated member receives and transfers the impact force to the spikes, forcing the elongated member to advance within the housing thereby exposing the spikes through an aperture in the distal end of the housing and permitting the spikes to impact the bone. In this embodiment, the exposure limiting facility of the apparatus limits the exposure of the spikes to a predetermined distance as discussed above.
With the release of the striking force (the mallet impact is rapidly removed), the disposing facility retracts the spikes into the housing thus preventing damage to the patient tissues and articular surfaces. The surgeon can then repeat these steps to continue the microfracture. At the completion of the microfracture, the apparatus can be removed.
With respect to the above description then, it is to be realized that the optimum dimensional relationships for the parts of the invention, to include variations in size, materials, shape, form, function and manner of operation, assembly and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by the present invention.
Therefore, the foregoing is considered as illustrative only of the principles of the invention. Further, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the invention. Although this invention has been described in the above forms with a certain degree of particularity, it is understood that the present disclosure has been made only by way of example and numerous changes in the details of construction and combination and arrangement of parts may be resorted to without departing from the spirit and scope of the invention. It is also understood that the methods and systems described can benefit a variety of surgical or similar procedures. Notwithstanding the specific example embodiments set forth above, all such variations and modifications that would be envisioned by one of ordinary skill in the art are intended to fall within the scope of this disclosure.
This application is a continuation of U.S. patent application Ser. No. 12/937,397 filed Oct. 12, 2010, which is a national phase application under 35 U.S.C. § 371 of International Application No. PCT/US2009/040581, filed Apr. 14, 2009, which claims the benefit of priority to U.S. Provisional Patent Application No. 61/045,144 filed on Apr. 15, 2008 which was entitled “RETRACTABLE SAFETY BONE PICK AND METHODS OF USE”, the entire contents of each of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2423511 | Luben | Jul 1947 | A |
3943932 | Woo | Mar 1976 | A |
4616649 | Burns | Oct 1986 | A |
5049150 | Cozad | Sep 1991 | A |
5356420 | Czernecki et al. | Oct 1994 | A |
5437675 | Wilson | Aug 1995 | A |
5667509 | Westin | Sep 1997 | A |
5741288 | Rife | Apr 1998 | A |
5741291 | Yoo | Apr 1998 | A |
5961535 | Rosenberg et al. | Oct 1999 | A |
6068642 | Johnson et al. | May 2000 | A |
6083238 | Alexander et al. | Jul 2000 | A |
6110178 | Zech et al. | Aug 2000 | A |
6146385 | Torrie et al. | Nov 2000 | A |
6193721 | Michelson | Feb 2001 | B1 |
6322574 | Lloyd et al. | Nov 2001 | B1 |
6322575 | Schraga | Nov 2001 | B1 |
6358253 | Torrie et al. | Mar 2002 | B1 |
6368326 | Dakin et al. | Apr 2002 | B1 |
6610067 | Tallarida et al. | Aug 2003 | B2 |
6692502 | Ertl et al. | Feb 2004 | B1 |
6712822 | Re et al. | Mar 2004 | B2 |
6960214 | Burkinshaw | Nov 2005 | B2 |
7029479 | Tallarida et al. | Apr 2006 | B2 |
7063703 | Reo | Jun 2006 | B2 |
7163542 | Ryan | Jan 2007 | B2 |
7241302 | Sniffen et al. | Jul 2007 | B2 |
7338494 | Ryan | Mar 2008 | B2 |
D581534 | Dong et al. | Nov 2008 | S |
7476226 | Weikel et al. | Jan 2009 | B2 |
7618462 | Ek | Nov 2009 | B2 |
7799033 | Assell et al. | Sep 2010 | B2 |
7942881 | Torrie et al. | May 2011 | B2 |
7967605 | Goodis | Jun 2011 | B2 |
8333769 | Browne et al. | Dec 2012 | B2 |
8394102 | Garabedian et al. | Mar 2013 | B2 |
8439947 | Howard et al. | May 2013 | B2 |
8821494 | Pilgeram | Sep 2014 | B2 |
8852201 | Schmieding et al. | Oct 2014 | B2 |
8911474 | Howard et al. | Dec 2014 | B2 |
9078740 | Steiner et al. | Jul 2015 | B2 |
9198676 | Pilgeram et al. | Dec 2015 | B2 |
9211126 | Sikora et al. | Dec 2015 | B2 |
9439947 | Guha et al. | Sep 2016 | B2 |
9510840 | Sikora et al. | Dec 2016 | B2 |
9572587 | Sikora et al. | Feb 2017 | B2 |
10039554 | Sikora et al. | Aug 2018 | B2 |
20020032447 | Weikel et al. | Mar 2002 | A1 |
20030083665 | Re et al. | May 2003 | A1 |
20030135209 | Seedhom et al. | Jul 2003 | A1 |
20040073223 | Burkinshaw | Apr 2004 | A1 |
20040087956 | Weikel et al. | May 2004 | A1 |
20040133208 | Weikel et al. | Jul 2004 | A1 |
20040147932 | Burkinshaw | Jul 2004 | A1 |
20040260300 | Gorensek et al. | Dec 2004 | A1 |
20050021067 | Kim | Jan 2005 | A1 |
20050038465 | Shraga | Feb 2005 | A1 |
20050043738 | Ryan | Feb 2005 | A1 |
20050137601 | Assell | Jun 2005 | A1 |
20050165404 | Miller | Jul 2005 | A1 |
20050177071 | Nakayama et al. | Aug 2005 | A1 |
20050177168 | Brunnett et al. | Aug 2005 | A1 |
20050209620 | Du et al. | Sep 2005 | A1 |
20060111729 | Bacastow et al. | May 2006 | A1 |
20060116705 | Schraga | Jun 2006 | A1 |
20060235419 | Steinwachs et al. | Oct 2006 | A1 |
20060241627 | Reo | Oct 2006 | A1 |
20060241630 | Brunnett et al. | Oct 2006 | A1 |
20060264955 | Abdelgany | Nov 2006 | A1 |
20070270870 | Torrie et al. | Nov 2007 | A1 |
20080045964 | Mishra | Feb 2008 | A1 |
20080071282 | Assell et al. | Mar 2008 | A1 |
20080114365 | Sasing et al. | May 2008 | A1 |
20080132932 | Hoeppner et al. | Jun 2008 | A1 |
20080177266 | Metcalf et al. | Jul 2008 | A1 |
20080249481 | Crainich et al. | Oct 2008 | A1 |
20080262383 | Routhier et al. | Oct 2008 | A1 |
20080294167 | Schumacher et al. | Nov 2008 | A1 |
20080300510 | Schwyn et al. | Dec 2008 | A1 |
20090076520 | Choi | Mar 2009 | A1 |
20090076615 | Duggal et al. | Mar 2009 | A1 |
20090143782 | Levi | Jun 2009 | A1 |
20090143809 | Assell et al. | Jun 2009 | A1 |
20090274996 | Miller | Nov 2009 | A1 |
20090312782 | Park | Dec 2009 | A1 |
20100076440 | Pamichev et al. | Mar 2010 | A1 |
20100082033 | Germain | Apr 2010 | A1 |
20100087823 | Kondrashov | Apr 2010 | A1 |
20100094297 | Parmigiani | Apr 2010 | A1 |
20100168616 | Schraga | Jul 2010 | A1 |
20100191195 | Kirschenbaum | Jul 2010 | A1 |
20100241124 | Housman et al. | Sep 2010 | A1 |
20100249786 | Schmieding et al. | Sep 2010 | A1 |
20100268282 | Trieu | Oct 2010 | A1 |
20100268285 | Tipirneni et al. | Oct 2010 | A1 |
20100312246 | Browne | Dec 2010 | A1 |
20100318139 | Beauchamp | Dec 2010 | A1 |
20110015675 | Howard et al. | Jan 2011 | A1 |
20110034930 | Buschmann et al. | Feb 2011 | A1 |
20110034945 | Paulos | Feb 2011 | A1 |
20110054612 | Dehnad et al. | Mar 2011 | A1 |
20110060349 | Cheng et al. | Mar 2011 | A1 |
20110063049 | Bradley et al. | Mar 2011 | A1 |
20110077653 | Haddock et al. | Mar 2011 | A1 |
20110238069 | Zajac et al. | Sep 2011 | A1 |
20110238126 | Soubeiran | Sep 2011 | A1 |
20110251615 | Truckai et al. | Oct 2011 | A1 |
20120071876 | Stoll et al. | Mar 2012 | A1 |
20120123485 | Dehnad et al. | May 2012 | A1 |
20120232558 | Berberich et al. | Sep 2012 | A1 |
20120271357 | Arthur et al. | Oct 2012 | A1 |
20130138046 | Feng | May 2013 | A1 |
20130317506 | Sikora et al. | Nov 2013 | A1 |
20140031825 | Torrie | Jan 2014 | A1 |
20140036656 | Chou et al. | Feb 2014 | A1 |
20140074102 | Mandeen et al. | Mar 2014 | A1 |
20140336656 | Rogers et al. | Nov 2014 | A1 |
20160022279 | Sikora et al. | Jan 2016 | A1 |
20160022280 | Sikora et al. | Jan 2016 | A1 |
20180008285 | Sikora et al. | Jan 2018 | A1 |
20190201007 | Sikora et al. | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
102011100695 | Nov 2012 | DE |
0082081 | Dec 1982 | EP |
WO 2003057045 | Jul 2003 | WO |
WO 2009129272 | Oct 2009 | WO |
WO 2011014677 | Feb 2011 | WO |
WO 2012103459 | Aug 2012 | WO |
WO 2013134500 | Sep 2013 | WO |
Entry |
---|
US 9,198,652 B2, 12/2015, Pilgeram (withdrawn) |
Benthien and Behrens, “The treatment of chondral and osteochondral defects of the knee with autologous matrix-induced chondrogenesis (AMIC): method description and recent develpments”, Knee Surg. Sports. Traumatol. Arthrosc., 2010, 4 pages. |
Extended European Search Report issued in corresponding European Application No. 15185091.4, dated Jan. 25, 2016. |
Gill et al., “The Treatment of Articular Cartilage Defects Using the Microfracture Technique”, Journal of Orthopedic & Sports Physical Therapy, 36(10):728-738, 2006. |
Girolamo et al., “Treatment of chondral defects of the knee with one step matrix-assisted technique enhanced by autologous concentrated bone marrow: In vitro characterization of mesenchymal stem cells from iliac crest and subchondral bone”, Injury, 41:1172-1177, 2010. |
International Preliminary Report on Patentability Issued in Corresponding PCT Application No. PCT/2009/040581, dated Oct. 28, 2010. |
International Search Report and Written Opinion issued in PCT Application No. PCT/US2013/029596, dated Jun. 19, 2013. |
International Search Report and Written Opinion Issued in PCT Application No. PCT/US2009/040581, dated Oct. 28, 2010. |
Number | Date | Country | |
---|---|---|---|
20190090887 A1 | Mar 2019 | US |
Number | Date | Country | |
---|---|---|---|
61045144 | Apr 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12937397 | US | |
Child | 16203443 | US |